Martin W Schoen

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Venues

Prostate cancer and prostatic diseases

The Prostate

Annals of internal medicine

JMIR human factors

Saint Louis University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Saint Louis University Jul 01 2019

United States

Assistant Professor :: Internal Medicine

VA St Louis Medical Center John Cochran Division Jul 01 2019

United States

Staff Physician :: Hematology/Oncology

Publications

Martin W Schoen, Kenneth R Carson, Seth A Eisen, Charles L Bennett, Suhong Luo, Melissa A Reimers, Eric M Knoche, Alison L Whitmer, Yan Yan, Bettina F Drake, Kristen M Sanfilippo
Correction to: Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases. Prostate cancer and prostatic diseases (2023)
Mei Wang, Yao-Chi Yu, Lawrence Liu, Martin W Schoen, Akhil Kumar, Kristin Vargo, Debbie L Bennett, Theodore Thomas, Su-Hsin Chang
Natural Language Processing-Assisted Classification Models to Confirm Monoclonal Gammopathy of Undetermined Significance and Progression in Veterans' Electronic Health Records. JCO clinical cancer informatics 7 (2023)
Srinivas Govindan, Nina Cheranda, Forest Riekhof, Suhong Luo, Martin W Schoen
Effect of BMI and hemoglobin A1c on survival of veterans with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide. The Prostate (2023)
Martin W Schoen, Kenneth R Carson, Seth A Eisen, Charles L Bennett, Suhong Luo, Melissa A Reimers, Eric M Knoche, Alison L Whitmer, Yan Yan, Bettina F Drake, Kristen M Sanfilippo
Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases. Prostate cancer and prostatic diseases (2022)
Amber Afzal, Brian F Gage, Luo Suhong, Martin W Schoen, Kevin Korenblat, Kristen M Sanfilippo
Different risks of hemorrhage in patients with elevated international normalized ratio from chronic liver disease versus warfarin therapy, a population-based retrospective cohort study. Journal of thrombosis and haemostasis : JTH 20 (7) (2022)
Jeromie Ballreich, Mariana P Socal, Charles L Bennett, Martin W Schoen, Antonio J Trujillo, Andrew Xuan, Gerard Anderson
Medicare Spending on Drugs With Accelerated Approval. Annals of internal medicine 175 (7) (2022)
Shamia Hoque, Brian J Chen, Martin W Schoen, Kenneth R Carson, Jesse Keller, Bartlett J Witherspoon, Kevin B Knopf, Y Tony Yang, Benjamin Schooley, Chadi Nabhan, Oliver Sartor, Paul R Yarnold, Paul Ray, Laura Bobolts, William J Hrushesky, Michael Dickson, Charles L Bennett
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia. PloS one 15 (6) (2020)
Martin W Schoen, Shamia Hoque, Bartlett J Witherspoon, Benjamin Schooley, Oliver Sartor, Y Tony Yang, Paul R Yarnold, Kevin B Knopf, William J M Hrushesky, Michael Dickson, Brian J Chen, Chadi Nabhan, Charles L Bennett
End of an era for erythropoiesis-stimulating agents in oncology. International journal of cancer 146 (10) (2020)
Martin W Schoen, Kenneth R Carson, Suhong Luo, Brian F Gage, Ang Li, Amber Afzal, Kristen M Sanfilippo
Venous thromboembolism in multiple myeloma is associated with increased mortality. Research and practice in thrombosis and haemostasis 4 (7) (2020)
Martin W Schoen, Ethan M Basch, Lori L Hudson, Arlene E Chung, Tito R Mendoza, Sandra A Mitchell, Diane St Germain, Paul Baumgartner, Laura Sit, Lauren J Rogak, Marwan Shouery, Eve R Shalley, Bryce B Reeve, Maria R Fawzy, Nrupen A Bhavsar, Charles S Cleeland, Deborah Schrag, Amylou C Dueck, Amy P Abernethy
Software for Administering the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study. JMIR human factors 5 (3) (2018)

Martin W Schoen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Martin W Schoen